HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

P N Durrington Selected Research

Lipids

12/2007Stroke prediction and stroke prevention with atorvastatin in the Collaborative Atorvastatin Diabetes Study (CARDS).
12/2006Genetic causes of familial hypercholesterolaemia in patients in the UK: relation to plasma lipid levels and coronary heart disease risk.
3/2006Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel.
4/2005Non-coronary heart disease mortality and risk of fatal cancer in patients with treated heterozygous familial hypercholesterolaemia: a prospective registry study.
8/2004Baseline characteristics in the Collaborative AtoRvastatin Diabetes Study (CARDS) in patients with Type 2 diabetes.
4/2003The effect of atorvastatin on serum lipids, lipoproteins and NMR spectroscopy defined lipoprotein subclasses in type 2 diabetic patients with ischaemic heart disease.
3/2002Design of the Collaborative AtoRvastatin Diabetes Study (CARDS) in patients with type 2 diabetes.
9/2001Paraoxonase status in coronary heart disease: are activity and concentration more important than genotype?
11/2000Apolipoproteins A-I, A-II and B, lipoprotein(a) and the risk of ischaemic heart disease: the Caerphilly study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


P N Durrington Research Topics

Disease

12Coronary Disease (Coronary Heart Disease)
04/2010 - 01/2000
8Type 2 Diabetes Mellitus (MODY)
01/2011 - 03/2002
7Cardiovascular Diseases (Cardiovascular Disease)
01/2008 - 03/2002
7Atherosclerosis
05/2003 - 05/2000
6Stroke (Strokes)
02/2009 - 12/2002
4Myocardial Infarction
09/2006 - 05/2001
3Vascular Diseases (Vascular Disease)
02/2009 - 01/2002
3Diabetes Mellitus
03/2008 - 03/2000
3Hypertension (High Blood Pressure)
08/2004 - 01/2002
2Neoplasms (Cancer)
04/2005 - 10/2004
2Heart Diseases (Heart Disease)
04/2003 - 11/2000
1Acute Coronary Syndrome
06/2012
1Proteinuria
01/2011
1Pancreatitis
08/2010
1Peripheral Vascular Diseases (Peripheral Vascular Disease)
03/2008
1Glucose Intolerance
04/2006
1Inflammation (Inflammations)
05/2003
1Sudden Death
05/2003
1Necrosis
01/2003
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
04/2002
1Arthritis (Polyarthritis)
01/2002
1Dyspepsia (Indigestion)
01/2002
1Persian Gulf Syndrome (Gulf War Syndrome)
09/2000
1Hepatocellular Carcinoma (Hepatoma)
06/2000
1Lipodystrophy
02/2000

Drug/Important Bio-Agent (IBA)

9LipidsIBA
12/2007 - 11/2000
8Atorvastatin (Lipitor)FDA Link
01/2011 - 03/2002
8Aryldialkylphosphatase (Paraoxonase)IBA
08/2004 - 01/2000
7Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
06/2012 - 12/2002
7Triglycerides (Triacylglycerol)IBA
08/2010 - 05/2001
6LDL Lipoproteins (beta Lipoproteins)IBA
04/2010 - 05/2000
6LDL CholesterolIBA
02/2009 - 01/2000
6CholesterolIBA
03/2008 - 01/2000
6oxidized low density lipoproteinIBA
04/2002 - 05/2000
5Apolipoproteins B (ApoB)IBA
02/2009 - 06/2000
4Lipoproteins (Lipoprotein)IBA
02/2009 - 06/2000
3Oxidoreductases (Dehydrogenase)IBA
01/2008 - 04/2005
3Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
10/2004 - 05/2001
2Simvastatin (Zocor)FDA LinkGeneric
06/2012 - 05/2001
2Apolipoprotein A-I (Apolipoprotein A1)IBA
02/2009 - 03/2006
2ApolipoproteinsIBA
02/2009 - 06/2000
2HDL CholesterolIBA
02/2009 - 03/2008
2Coenzyme A (CoA)IBA
01/2008 - 12/2005
2CreatinineIBA
12/2007 - 08/2004
2AlbuminsIBA
12/2007 - 08/2004
2OmacorFDA Link
05/2003 - 05/2001
1EnzymesIBA
01/2008
1Hydroxyl RadicalIBA
01/2008
1LDL Receptors (LDL Receptor)IBA
12/2006
1Nonesterified Fatty Acids (NEFA)IBA
04/2006
1FatsIBA
10/2004
1Blood Coagulation Factors (Coagulation Factor)IBA
05/2003
1CollagenIBA
01/2003
1Antihypertensive Agents (Antihypertensives)IBA
12/2002
1Pharmaceutical PreparationsIBA
12/2002
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2002
1Amino AcidsFDA Link
09/2001
1Lipid PeroxidesIBA
09/2001
1Fish OilsIBA
05/2001
1Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
05/2001
1Oxidants (Oxidizing Agents)IBA
04/2001
1Phospholipids (Phosphatides)FDA LinkGeneric
02/2001
1Cholesterol Esters (Cholesteryl Esters)IBA
02/2001
1Apolipoproteins AIBA
11/2000
1Lipoprotein(a)IBA
11/2000
1OrganophosphatesIBA
09/2000
1GasesIBA
09/2000
1InsecticidesIBA
09/2000
1Fatty Acids (Saturated Fatty Acids)IBA
06/2000
1Lamin Type A (Lamin A)IBA
02/2000
11-dodecylpyridoxal (PLD)IBA
02/2000

Therapy/Procedure

5Therapeutics
03/2008 - 03/2002
2Drug Therapy (Chemotherapy)
04/2005 - 12/2002